Seoul, Seoul-t'ukpyolsi, South Korea Shinhan Capital is the famous VC, which was founded in 1991. The venture was found in Asia in South Korea. The main office of represented VC is situated in the Seoul.
When the investment is from Shinhan Capital the average startup value is 5-10 millions dollars. The high activity for fund was in 2016. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are FinTech, EdTech. Among the most popular portfolio startups of the fund, we may highlight True Balance, Mesh Korea, Vedanta Biosciences. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little.
The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Shinhan Capital, startups are often financed by Shinhan Bank, Yellow Financial Group, Softbank Ventures Asia. The meaningful sponsors for the fund in investment in the same round are KB Investment, Hanwha Investment Corp, Symbiosis. In the next rounds fund is usually obtained by Murex Partners, KB Investment, Bass Investment.
Related Funds
| Fund Name | Location |
| Blue Angels Investment Group | Boston, Massachusetts, United States |
| Chongqing Dongzheng Huaixin Guquan Touzi Jijin Hehuo Qiye (Youxian Hehuo) | China, Chongqing, Jiulongpo |
| Cogito Ventures | - |
| Crossroads Capital | Colorado, Greenwood Village, United States |
| Delphi VC | New York, New York, United States |
| DJI | China, Guangdong, Shenzhen |
| Guangdong Hongmi Touzi Hehuo Qiye (Putong Hehuo) | China, Guangdong, Zhangshan |
| Invest In Visions | - |
| Kashen Jinsheng Tianhua | - |
| KLEOSS Capital | Gauteng, Johannesburg, South Africa |
| MF Private Capital | Boston, Massachusetts, United States |
| Northwater Capital | Canada, Ontario, Toronto |
| Opium Ventures | China, Hong Kong, Hong Kong Island |
| Ruian Real Estate Development Management | China, Shanghai |
| Seibu Shinkin Capital | Japan, Kumamoto, Kumamoto Prefecture |
| Seoul Investment Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
| Shengjing Technology | - |
| Societe Generale | France, Ile-de-France, Paris |
| University of Toronto Asset Management Corporation | Canada, Ontario, Toronto |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Avelos Therapeutics | $14M | 02 May 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Testbank | $2M | 13 Mar 2024 | Seongnam, Kyonggi-do, South Korea | ||
ELROILAB | $4M | 22 Jan 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
CURAUM | $9M | 26 Sep 2023 | Daejeon, Taejon-jikhalsi, South Korea | ||
CLE | $3M | 04 Sep 2023 | Kyonggi-do, Gyeonggi-do, South Korea | ||
GTL | $2M | 09 Aug 2023 | South Korea, Gangwon-do, South Korea | ||
CLOP | 28 Jun 2023 | - | |||
Cashwalk | $26M | 12 Apr 2023 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
KevinLAB | $3M | 02 Feb 2023 | Ansan, Inch'on-jikhalsi, South Korea |
– Speclipse is a Seoul, South Korea-based developer of laser spectroscopic and AI-based medical diagnosis technologies.
– The company raised $7.7m in funding.
– The round was led by Signite Partners with participation from BNH Investment, Shinhan Capital, MiCo and MiCoBioMed.
– The new investment will be used to accelerate growth, expand operations and its business reach.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Avelos Therapeutics | $14M | 02 May 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Testbank | $2M | 13 Mar 2024 | Seongnam, Kyonggi-do, South Korea | ||
ELROILAB | $4M | 22 Jan 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
CURAUM | $9M | 26 Sep 2023 | Daejeon, Taejon-jikhalsi, South Korea | ||
CLE | $3M | 04 Sep 2023 | Kyonggi-do, Gyeonggi-do, South Korea | ||
GTL | $2M | 09 Aug 2023 | South Korea, Gangwon-do, South Korea | ||
CLOP | 28 Jun 2023 | - | |||
Cashwalk | $26M | 12 Apr 2023 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea | ||
KevinLAB | $3M | 02 Feb 2023 | Ansan, Inch'on-jikhalsi, South Korea |
